Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex: day-to-day and diurnal variations.
Abstract
METHODS have been described for the measurement of total 17-ketosteroids (17-KS) occurring in human plasma (1) and for their fractionation (2). Dehydroepiandrosterone (DHA) and androsterone have been isolated and found to be the principal 17-KS in the peripheral circulation of normal man (3, 4). The present study was carried out in order to obtain further information on the levels of DHA and androsterone in normal subjects and to ascertain the effect of age and sex on the concentrations of these steroids. It was also thought to be of interest to determine the diurnal variation as well as the day-to-day changes of the 17-KS levels in the same subjects. A 40-ml. sample of blood was drawn from each experimental subject between 8:30 and 9:30 a.m., except in the study of diurnal variations, when blood was obtained at various times of the day. The blood samples were heparinized. They were centrifuged within forty-five minutes following collection and the plasma was immediately separated from the red cells. When the determination was not carried out immediately, the plasma was kept in a freezer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Serum androgens as well as their precursors and metabolites decrease from the age of 30-40 yr in women.
“Serum androgens as well as their precursors and metabolites decrease from the age of 30 -40 yr in women”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [22]
At 70 yr of age, serum DHEA-S levels are decreased to approximately 20% of their peak values, whereas they can decrease by 95% by the age of 85-90 yr.
“at 70 yr of age, serum DHEA-S levels are decreased to approximately 20% of their peak values, whereas they can decrease by 95% by the age of 85-90 yr (22).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [22]
Cited by
Sorted by citations
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713 · see citing works
Baulieu, E.-E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M.-P., Latour, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4279 · Cited by 577 · see citing works
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544 · see citing works
“In fact, as mentioned earlier, at 70 yr of age, serum DHEA-S levels are decreased to approximately 20% of their peak values, whereas they can decrease by 95% by the age of 85–90 yr (22).”
BackgroundIs dehydroepiandrosterone a hormone?
Labrie, F., Luu-The, V., Bèlanger, A., Lin, S.-X., Simard, J., Pelletier, G., & Labrie, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06264 · Cited by 454 · see citing works
“…physiology has removed attention from the dramatic 70% fall in circulating DHEA which already occurs between the ages of 20 to 30 and 40 to 50 years (Migeon et al. 1957, Vermeulen & Verdonck 1976, Vermeulen et al. 1982, Orentreich et al. 1984, Bélanger et al. 1994, Labrie et al. 1997d) (Fig.”
BackgroundInfluentialField, A. E., Colditz, G. A., Willett, W. C., Longcope, C., & McKinlay, J. B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962322 · Cited by 421 · see citing works
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Ibáñez, L., DiMartino-Nardi, J., Potau, N., & Saenger, P. H. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0416 · Cited by 414 · see citing works
Age-related Changes in Sebaceous Gland Activity
Pochi, P. E., Strauss, J. S., & Downing, D. T. (1979) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12532792 · Cited by 365 · see citing works
Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366 · see citing works
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350 · see citing works
Berr, C., Lafont, S., Debuire, B., Dartigues, J., & Baulieu, É.-É. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13410 · Cited by 292 · see citing works
DHEA and peripheral androgen and estrogen formation: intracrinology
LABRIE, F., BÉLANGER, A., SIMARD, J., LUU‐THE, V., & LABRIE, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17369.x · Cited by 280 · see citing works
Labrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4306 · Cited by 292 · see citing works
RETRACTED: Chronic Inflammation: Accelerator of Biological Aging
Fougère, B., Boulanger, É., Nourhashémi, F., Guyonnet, S., & Cesari, M. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw240 · Cited by 247 · see citing works
“On the contrary, levels of growth hormone (GH), dehydroepiandrosterone (DHEA) and its circulating form DHEA sulfate (DHEAS) decrease with age (28).”
BackgroundRetractedGordon, G., Bush, D. E., & Weisman, H. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113652 · Cited by 241 · see citing works
“Circulating levels of DHEAand its sulfate, dehydroepiandrosterone sulfate (DHEAS), decline profoundly with age as the incidences of atherosclerosis and cancer rise (10-13).”
BackgroundResultGuazzo, E., Kirkpatrick, P. J., Goodyer, I. M., Shiers, H. M., & Herbert, J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923843 · Cited by 228 · see citing works
STEROID HORMONES IN THE BRAIN: SEVERAL MECHANISMS?
Baulieu, E. (1981) · Elsevier eBooks · doi:10.1016/b978-0-08-026864-4.50007-4 · Cited by 221 · see citing works
Parker, C. R. (1999) · Steroids · doi:10.1016/s0039-128x(99)00046-x · Cited by 202 · see citing works
KORTH-SCHÜTZ, S., Levine, L. S., New, M. I., & CHOW, D. M. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-1-117 · Cited by 193 · see citing works
Loria, R. M., Inge, T. H., Cook, S. S., Szakal, A. K., & Regelson, W. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890260310 · Cited by 180 · see citing works
The Rise in Adrenal Androgen Biosynthesis: Adrenarche
Havelock, J. C., Auchus, R. J., & Rainey, W. E. (2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-861550 · Cited by 178 · see citing works
Stress, glucocorticoids and ageing of the immune system
Bauer, M. E. (2005) · Stress · doi:10.1080/10253890500100240 · Cited by 184 · see citing works
“Serum DHEA levels decrease by the second decade of life reaching about 5% of the original level in the elderly (Migeon et al. 1957).”
BackgroundAn update of congenital adrenal hyperplasia
NEW, M. I. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1315.009 · Cited by 178 · see citing works
Dehydroepiandrosterone as a regulator of immune cell function
Hazeldine, J., Arlt, W., & Lord, J. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.016 · Cited by 173 · see citing works
Mazat, L., Lafont, S., Berr, C., Debuire, B., Tessier, J.-F., Dartigues, J., & Baulieu, É.-É. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121177998 · Cited by 172 · see citing works
The Role of Stress Factors during Aging of the Immune System
Bauer, M. E., Jeckel, C. M. M., & Luz, C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03966.x · Cited by 167 · see citing works
Normal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 163 · see citing works
Luchetti, S., Huitinga, I., & Swaab, D. F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.010 · Cited by 151 · see citing works
“The levels of both ecline with age (Migeon et al., 1957; Morley et al., 1997; rentreich et al., 1992).”
Herrington, D. M., Gordon, G. B., Achuff, S. C., Trejo, J. F., Weisman, H. F., Kwiterovich, P. O., & Pearson, T. A. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80334-1 · Cited by 147 · see citing works
Potential biomarkers of ageing
Simm, A., Naß, N., Bartling, B., Hofmann, B., Silber, R., & Santos, A. N. (2008) · Biological Chemistry · doi:10.1515/bc.2008.034 · Cited by 146 · see citing works
“Blood levels of DHEA decline after a peak at age 25–30 years to approximately 10–20% of this level by age 80 years (Migeon et al., 1957).”
BackgroundSerum dehydroepiandrosterone sulfate levels as an individual marker
Thomas, G., Frénoy, N., Legrain, S., Sebag-Lanoë, R., Baulieu, E. E., & Debuire, B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962319 · Cited by 142 · see citing works
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
Nestler, J. E., & Strauss, J. F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30245-7 · Cited by 133 · see citing works
Impact of DHEA(S) and cortisol on immune function in aging: a brief review
Buford, T. W., & Willoughby, D. S. (2008) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h08-013 · Cited by 132 · see citing works
“DHEA production begins to decline shortly after puberty, and can reach 5% of its original levels in the elderly (Migeon et al. 1957).”
BackgroundDanenberg, H. D., Alpert, G., Lustig, S., & Ben‐Nathan, D. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2275 · Cited by 129 · see citing works
Morfin, R. F., & Courchay, G. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90176-7 · Cited by 129 · see citing works
Metabolism of DHEA in postmenopausal women following percutaneous administration
Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Chaussade, V., Castiel, I., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.034 · Cited by 129 · see citing works
Dehydroepiandrosterone and Structural Analogs: A New Class of Cancer Chemopreventive Agents
Schwartz, A. G., Whitcomb, J. M., Nyce, J. W., Lewbart, M. L., & Pashko, L. L. (1988) · Advances in cancer research · doi:10.1016/s0065-230x(08)60227-4 · Cited by 128 · see citing works
Eich, D., Nestler, J. E., Johnson, D. E., Dworkin, G. H., Ko, D., Wechsler, A. S., & Hess, M. L. (1993) · Circulation · doi:10.1161/01.cir.87.1.261 · Cited by 126 · see citing works
Androgen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127 · see citing works
“, turns on 17,20 lyase activity) [67–69].”
Nyce, J. W., MAGEE, P. N., Hard, G. C., & Schwartz, A. G. (1984) · Carcinogenesis · doi:10.1093/carcin/5.1.57 · Cited by 125 · see citing works
Araneo, B. A., Woods, M. L., & Daynes, R. A. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.830 · Cited by 123 · see citing works
“The age-dependent decline in endogenous DHEA production is well recognized and provides an excellent model to evaluate the biologic functions of DHEA and its metabolites [4, 5].”
BackgroundLaCroix, A. Z., Yano, K., & REED, D. M. (1992) · Circulation · doi:10.1161/01.cir.86.5.1529 · Cited by 118 · see citing works
“(5-65)* (66-92)* (93-114)* (115-140)* (141-277)* Variable (n=96)t (n=93)t (n=99)t (n=91)t (n=97)t”
Guercio, G., Rivarola, M. A., Chaler, E., Maceiras, M., & Belgorosky, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020979 · Cited by 116 · see citing works
“00/0 The Journal of Clinical Endocrinology & Metabolism 88(3):1389–1393”
BackgroundInfluentialParker, C., Slayden, S. M., Azziz, R., Crabbe, S. L., Hines, G. A., Boots, L. R., & Bae, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6265 · Cited by 129 · see citing works
Nestler, J. E., Usiskin, K., BARLASCINI, C. O., Welty, D. F., Clore, J. N., & Blackard, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-5-1040 · Cited by 115 · see citing works
Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid.
ROBEL, P., & BAULIEU, E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17374.x · Cited by 112 · see citing works
Chronic Stress and Immunosenescence: A Review
Bauer, M. E. (2008) · NeuroImmunoModulation · doi:10.1159/000156467 · Cited by 108 · see citing works
Neuroendocrine and Immunological Correlates of Chronic Stress in ‘Strictly Healthy’ Populations
Jeckel, C. M. M., Lopes, R. P., Berleze, M. C., Luz, C., Feix, L. D. F., Argimon, I. I. D. L., Stein, L. M., & Bauer, M. E. (2009) · NeuroImmunoModulation · doi:10.1159/000243080 · Cited by 107 · see citing works
The Adrenarche: Prolactin, Gonadotropins, Adrenal Androgens, and Cortisol
Parker, L. N., Sack, J., Fisher, D. A., & Odell, W. D. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-3-396 · Cited by 102 · see citing works
Hemsell, D. L., Edman, C. D., Marks, J. F., Siiteri, P. K., & MacDonald, P. C. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108796 · Cited by 100 · see citing works
Gordon, G., Bush, T. L., Helzlsouer, K. J., Miller, S. R., & Comstock, G. W. (1990) · PubMed · Cited by 105 · see citing works
Serum Androgens as a Continuing Index of Adequacy of Treatment of Congenital Adrenal Hyperplasia*
KORTH-SCHÜTZ, S., Virdis, R., Saenger, P. H., CHOW, D. M., Levine, L. S., & New, M. I. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-3-452 · Cited by 103 · see citing works
Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging
Ferrari, E., Casarotti, D., Muzzoni, B., Albertelli, N., Cravello, L., Fioravanti, M., Solerte, S. B., & Magri, F. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00133-3 · Cited by 97 · see citing works
Legrain, S., Massien, C., Lahlou, N., Roger, M., Debuire, B., Diquet, B., Châtellier, G., Azizi, M., Faucounau, V., Porchet, H. C., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6805 · Cited by 104 · see citing works
Insulin inhibits adrenal 17,20-lyase activity in man
Nestler, J. E., McClanahan, M. A., Clore, J. N., & Blackard, W. G. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.2.1730815 · Cited by 96 · see citing works
Steroid hormones and CNS sexual dimorphisms modulate symptom expression in tourette's syndrome
Peterson, B. S., Leckman, J. F., Scahill, L. D., Naftolin, F. N., Keefe, D., Charest, N. J., & Cohen, D. J. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90015-y · Cited by 90 · see citing works
Dehydroepiandrosterone Sulphate (DHEAS) in the Oldest Old, Aged 85 and Overa
Birkenhäger‐Gillesse, E. G., Derksen, J. J. L., & Lagaay, A. M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56858.x · Cited by 89 · see citing works
Dehydroepiandrosterone (DHEA)‐the “Mother Steroid”
Action, I. I., Regelson, W., Loria, R. M., & Kalimi, M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56859.x · Cited by 89 · see citing works
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia
Labrie, F., Archer, D. F., Bouchard, C., Fortier, M. P., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N. J., Moreau, M., et al. (2011) · Climacteric · doi:10.3109/13697137.2010.535226 · Cited by 88 · see citing works
Shantz, L. M., Talalay, P., & Gordon, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3852 · Cited by 87 · see citing works
Saez, J. M., & Bertrand, J. (1968) · Steroids · doi:10.1016/s0039-128x(68)80029-7 · Cited by 85 · see citing works
Charalampopoulos, I., Dermitzaki, E., Vardouli, L., Tsatsanis, C., Stournaras, C., Margioris, A. N., & Gravanis, A. (2005) · Endocrinology · doi:10.1210/en.2005-0263 · Cited by 82 · see citing works
An Update of Congenital Adrenal Hyperplasia
New, M. I., Dupont, B., PANG, S., Pollack, M. S., & Levine, L. S. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-571137-1.50008-6 · Cited by 83 · see citing works
Role of DHEA in cardiovascular diseases
Savineau, J., Marthan, R., & de la Roque, E. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.004 · Cited by 78 · see citing works
“DHEA is the most abundant adrenal steroid and serum concentrations of its 3b-sulphate ester (DHEA-S) are approximately 20-fold higher than those of any other circulating steroid hormone [2,3].”
BackgroundNeurobiology of DHEA and effects on sexuality, mood and cognition
Pluchino, N., Drakopoulos, P., Bianchi‐Demicheli, F., Wenger, J. M., Petignat, P., & Genazzani, A. R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.012 · Cited by 76 · see citing works
Charalampopoulos, I., Alexaki, V. I., Lazaridis, I., Dermitzaki, E., Avlonitis, N., Tsatsanis, C., Calogeropoulou, T., Margioris, A. N., Castanas, E., & Gravanis, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5078fje · Cited by 78 · see citing works
Dehydroepiandrosterone and coronary atherosclerosis
HERRINGTON, D. M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17387.x-i1 · Cited by 75 · see citing works
Hormonal Intervention: “Buffer Hormones” or “State Dependency”
Regelson, W., Loria, R. M., & Kalimi, M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb35284.x · Cited by 75 · see citing works
Smith, M. R., Rudd, B. T., Shirley, A., RAYNER, P. H. W., Williams, J. W., Duignan, N. M., & Bertrand, P. V. (1975) · Clinica Chimica Acta · doi:10.1016/0009-8981(75)90328-9 · Cited by 73 · see citing works
Biochemical Markers of Aging for Longitudinal Studies in Humans
Engelfriet, P. M., Jansen, E. H. J. M., Picavet, H. S. J., & Dollé, M. E. T. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs011 · Cited by 74 · see citing works
“Luteinizing hormone, folliclestimulating hormone, dehydroepiandrosterone (62–63, 176) (174) (review) 1 Serum/plasma Autoanalyzer High (61)”
BackgroundRole of neuroendocrine pathways in cognitive decline during aging
Ferrari, E., & Magri, F. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.001 · Cited by 71 · see citing works
Decreased adrenal androgen sensitivity to ACTH during aging
Parker, L., Grál, T., Perrigo, V., & Skowsky, R. (1981) · Metabolism · doi:10.1016/0026-0495(81)90139-6 · Cited by 71 · see citing works
Dehydroepiandrosterone Inhibits Human Platelet Aggregation in Vitro and in Vivoa
Jesse, R. L., Loesser, K. E., Eich, D., Qian, Y. Z., Hess, M. L., & Nestler, J. E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17388.x-i1 · Cited by 71 · see citing works
Li, S., Yan, X., B�langer, A., & Labrie, F. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00665681 · Cited by 70 · see citing works
“peak values while they decrease by up to 95 % by the age of 85 to 90 years [ 13 ].”
BackgroundLloyd‐Evans, E., & Waller‐Evans, H. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200043 · Cited by 71 · see citing works
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly?
Genazzani, A. D., Lanzoni, C., & Genazzani, A. R. (2007) · Drugs & Aging · doi:10.2165/00002512-200724030-00001 · Cited by 69 · see citing works
Iglesias, G. G., Mendoza-Milla, C., Zapata, E., Montiel, A., Reyes, E., Montaño, L. F., & López‐Marure, R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.031 · Cited by 66 · see citing works
GROWTH HORMONE SECRETION IN CHILDREN DETERMINED BY TIME SERIES ANALYSIS
Hindmarsh, P. C., Matthews, D. R., & Brook, C. G. D. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb00247.x · Cited by 61 · see citing works
“This conclusion is supported by the observations of Stolar and Bauman (1986) that important oscillatory GH secretion is occurring at these levels and highlights the need to use several methods of pulse analysis. A similar situation was encountered by Link et al. (1986) using an iterative method to analyse GH pulse amp…”
ResultDehydroepiandrosterone: An anti‐obesity and anti‐carcinogenic agent
Schwartz, A. G., Hard, G. C., Pashko, L. L., Abou-Gharbia, M. A., & Swern, D. (1981) · Nutrition and Cancer · doi:10.1080/01635588109513700 · Cited by 63 · see citing works
DHEAS as an Effective Vaccine Adjuvant in Elderly Humans
Araneo, B. A., Dowell, T., Woods, M. L., Daynes, R. A., JUDD, M., & Evans, T. G. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17384.x-i1 · Cited by 60 · see citing works
Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis
Tabata, N., Tagami, H., & Terui, T. (1997) · Archives of Dermatological Research · doi:10.1007/s004030050213 · Cited by 58 · see citing works
“... physiological functions have been ascribed to this steroid, many observations have indicated the existence of various biological responses to DHEA including susceptibility to infectious agents, immunosenescence, mucosal immunity [2], and antitumor and antidiabetic activities [3, 4]. DHEA shows intriguing biologica…”
BackgroundSchneider, E. L., & Reed, J. D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505023121805 · Cited by 60 · see citing works
Baulieu, É.-É. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00367-2 · Cited by 58 · see citing works
Gordon, G., Newitt, J. A., Shantz, L. M., Weng, D. E., & Talalay, P. (1986) · PubMed · Cited by 57 · see citing works
Khalil, A., Fortin, J. P., Lehoux, J., & Fülöp, T. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31987-8 · Cited by 57 · see citing works
Steroid Metabolism in the Fetoplacental Unit and in Early Childhood
Mitchell, F. L. (1967) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60037-0 · Cited by 58 · see citing works
Lebrethon, M. C., Jaillard, C., Naville, D., Bégeot, M., & Saez, J. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962271 · Cited by 59 · see citing works
Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer.
Gordon, G., Helzlsouer, K. J., & Comstock, G. W. (1991) · PubMed · Cited by 56 · see citing works
3β-HSD activates DHEA in the songbird brain
Schlinger, B. A., Pradhan, D. S., & Soma, K. K. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.05.003 · Cited by 52 · see citing works
“1b) is an abundant circulating hormone in humans and, together with DHEA-S, constitutes the most abundant steroid hormone secreted by the human adrenal cortex (Migeon et al., 1957;Odell and Parker, 1984).”
BackgroundGuercio, G., Rivarola, M. A., Chaler, E., Maceiras, M., & Belgorosky, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8330 · Cited by 54 · see citing works
“1164 J Clin Endocrinol Metab, March 2002, 87(3):1162–1169 Guercio et al.”
BackgroundInfluentialEvans, T. G. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00095-3 · Cited by 51 · see citing works
Protection by dehydroepiandrosterone in mice infected with viral encephalitis
Ben‐Nathan, D., Lachmi, B., Lustig, S., & Feuerstein, G. Z. (1991) · Archives of Virology · doi:10.1007/bf01310481 · Cited by 50 · see citing works
Kassem, L. S., Sibai, K. E., Chaiban, J. T., Abdelmannan, D. K., & Arafah, B. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1806 · Cited by 50 · see citing works
“DHEA-S has a long half-life of around 20 h that provides constant levels throughout the day (15, 16), whereas DHEA has a shorter half-life of 1–3 h and has been shown to have less diurnal variation than cortisol (14).”
BackgroundPhysicochemical characterization of [3H] DHEA binding in rat liver
Kalimi, M., & Regelson, W. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80800-3 · Cited by 50 · see citing works
Involvement of steroids and cytochromes P450 species in the triggering of immune defenses
Morfin, R. F. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00025-0 · Cited by 49 · see citing works
Araghi‐Niknam, M., Liang, B., Zhang, Z., Ardestani, S. K., & WATSON, R. R. (1997) · Immunology · doi:10.1111/j.1365-2567.1997.00344.x · Cited by 49 · see citing works
Radioligand assay for Δ5-3β-hydroxysteroids I. 3β-hydroxy-5-androstene-17-one and its 3-sulfate
Nieschlag, E., Loriaux, D. L., & LIPSETT, M. B. (1972) · Steroids · doi:10.1016/s0039-128x(72)80032-1 · Cited by 49 · see citing works
Zapata, E., Ventura, J. L., la Cruz, K. D., Rodrı́guez, E., Damián, P., Massó, F., Montaño, L. F., & López‐Marure, R. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04563.x · Cited by 47 · see citing works
Orentreich∥, N., & Durr, N. P. (1982) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)30347-3 · Cited by 46 · see citing works
The Investigation of Steroid Metabolism in Early Infancy
Mitchell, F. L., & Shackleton, C. H. L. (1969) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60259-0 · Cited by 46 · see citing works
Dardis, A., Saraco, N., Rivarola, M. A., & Belgorosky, A. (1999) · Pediatric Research · doi:10.1203/00006450-199903000-00016 · Cited by 45 · see citing works
- Authors
- MIGEON, C. J., KELLER, A. R., LAWRENCE, B., & SHEPARD, T. H.
- Affiliations
- Johns Hopkins University (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1957-09
- Volume
- 17
- Issue
- 9
- Pages
- 1051-1062
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2144503086
- Cited by
- 260
- References
- 0
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 2 · 2014: 3 · 2013: 4 · 2012: 4
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Keywords
- dehydroepiandrosterone, androsterone, 17-ketosteroids, plasma steroid levels, age differences, sex differences, diurnal variation, day-to-day variability
- MeSH terms
- Aging, Androgens, Androsterone, Circadian Rhythm, Dehydroepiandrosterone, Humans, Sex Characteristics, Sexual Maturation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review